Inovio Pharmaceuticals Q3 EPS $(0.87) Misses $(0.42) Estimate

Inovio Pharmaceuticals (NASDAQ: INO) reported quarterly losses of $(0.87) per share which missed the analyst consensus estimate of $(0.42) by 105.67 percent. This is a 2.25 percent increase over losses of $(0.89) per share from the same period last year.